Published quarterly, the AIM Advisers Guide ranks the top 20 auditors, financial advisers, financial PRs, law firms, registrars, and stockbrokers by client numbers.
Andrew Parson, publisher of the AIM Advisers Guide, commented: “Jeffreys Henry added three new clients, which was more than any other auditor this quarter, and has consequently taken ninth place in the rankings from EY.”
With a total of 41 UK listed clients**, including 27 on AIM, Jeffreys Henry specialist Capital Markets Team provide a cost-effective audit and reporting accountant services to companies already listed, or considering listing, on the London Stock Exchange, AIM, Aquis and other European markets.
Camillus Glover, CFO of DeepVerge Plc, previously commented: “Nick, Sanjay and their team have the perfect combination of expertise of a large firm with the approachability and flexibility of a smaller firm. They are an ideal fit for small-cap AIM businesses like ours that require additional support, their advice goes beyond normal compliance and they have guided us through several acquisitions as well as providing a quality audit service. We have been a client of Jeffreys Henry for 8 years and although their role is one of as advisor/auditor it feels more like a partnership.”
* Issue 36 – April 2022, AIM Advisers Guide
** As of April 2022
Partner - Capital Markets
Partner - Capital Markets
23 December 2021
Jeffreys Henry, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has advised Aptamer Group Plc on its £80.7 million AIM IPO. On Admission, the market capitalisation of Aptamer Group was approximately £80.7 million. The Placing raised gross proceeds of £10.8 million and attracted strong support from high-quality institutional investors.
24 November 2021
Jeffreys Henry, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has recently advised Technology Minerals Plc on its £27.3 million IPO on the Standard Segment of LSE’s Main Market.
20 July 2021
Poolbeg Pharma, a spin out of Open Orphan, has successfully raised £25 million (before expenses) and lists with a market capitalisation of £50 million. Poolbeg Pharma is a clinical-stage infectious disease pharmaceutical company. Their novel capital light clinical model enables them to develop multiple products faster and more cost effectively than the traditional biotech model.
5 January 2021
Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has advised Vector Capital Plc on its […]
16 December 2020
Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has advised Intuitive Investments Group on its […]
3 November 2020
Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has recently advised Anemoi International (“AMOI”) on its IPO on the Standard Segment of LSE’s main market.
6 October 2020
Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has recently advised Mode Global Holdings Plc, a UK based founder led fintech group, on its £40.3 million IPO on the Standard Segment of LSE’s main market.
21 July 2020
We are delighted to announce that our specialist Capital Markets team have been shortlisted for one of the most hotly-contested trophies in the accountancy profession: Specialist Team of the Year 2020.